NeoGenomics, Inc. Gain (Loss) on Extinguishment of Debt
NeoGenomics, Inc. (NEO) reported Gain (Loss) on Extinguishment of Debt of $11.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-07-28
- NeoGenomics, Inc. gain (loss) on extinguishment of debt for the quarter ending 2026-06-30 was $11.18M.
- NeoGenomics, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-06-30 was $0.00.
- NeoGenomics, Inc. gain (loss) on extinguishment of debt for the quarter ending 2021-12-31 was $0.00.
- NeoGenomics, Inc. gain (loss) on extinguishment of debt for the quarter ending 2021-09-30 was $0.00.
- NeoGenomics, Inc. gain (loss) on extinguishment of debt for fiscal 2022 was $0.00.
- NeoGenomics, Inc. gain (loss) on extinguishment of debt for fiscal 2021 was $0.00.
- NeoGenomics, Inc. gain (loss) on extinguishment of debt for fiscal 2020 was -$1.40M.
- NeoGenomics, Inc. gain (loss) on extinguishment of debt for fiscal 2019 was -$1.02M.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.18M 10-Q · filed 2026-07-28 | $11.18M 10-Q · filed 2026-07-28 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-07-28 | $0.00 10-Q · filed 2026-07-28 | ||
| 2022-12-31 | $0.00 10-K · filed 2023-02-24 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $0.00 derived: sum of 2 quarters · filed 2023-02-24 | $0.00 derived: sum of 3 quarters · filed 2023-02-24 | $0.00 10-K · filed 2023-02-24 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $0.00 derived: sum of 2 quarters · filed 2023-02-24 | -$1.40M derived: sum of 3 quarters · filed 2023-02-24 | -$1.40M 10-K · filed 2023-02-24 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 | -$1.40M derived: sum of 2 quarters · filed 2021-11-04 | -$1.40M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$1.40M 10-Q · filed 2021-08-09 | -$1.40M 10-Q · filed 2021-08-09 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | -$1.02M derived: sum of 3 quarters · filed 2022-02-25 | -$1.02M 10-K · filed 2022-02-25 |
| 2019-09-30 | $0.00 10-Q · filed 2020-10-29 | -$1.02M derived: sum of 2 quarters · filed 2020-10-29 | -$1.02M 10-Q · filed 2020-10-29 | |
| 2019-06-30 | -$1.02M 10-Q · filed 2020-07-31 | -$1.02M 10-Q · filed 2020-07-31 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-13 | $0.00 derived: sum of 2 quarters · filed 2019-11-13 | $0.00 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-07 | $0.00 10-Q · filed 2019-08-07 | ||
| 2017-12-31 | $0.00 10-K · filed 2020-02-28 | |||
| 2016-12-31 | -$1.10M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |